Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
暂无分享,去创建一个
Anil K Patri | James R Baker | J. Baker | A. Patri | J. Kukowska-Latallo | Jolanta F Kukowska-Latallo | J. Baker
[1] Hisataka Kobayashi,et al. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. , 2003, Bioconjugate chemistry.
[2] Anthony E. Beezer,et al. The synthesis of water soluble dendrimers, and their application as possible drug delivery systems , 1999 .
[3] M. Brechbiel,et al. Specific targeting of folate–dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.
[4] L R Coney,et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. , 1992, Cancer research.
[5] K. Kono,et al. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. , 2000, Bioconjugate chemistry.
[6] P C Lauterbur,et al. Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents , 1994, Magnetic resonance in medicine.
[7] James R. Dewald,et al. A New Class of Polymers: Starburst-Dendritic Macromolecules , 1985 .
[8] A. Beezer,et al. Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives , 2003 .
[9] D. Tomalia,et al. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. , 2001, Drug discovery today.
[10] J. Reddy,et al. Folate-targeted chemotherapy. , 2004, Advanced drug delivery reviews.
[11] Thommey P. Thomas,et al. Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor , 2002, Pharmaceutical Research.
[12] William A. Goddard,et al. Starburst Dendrimers: Molecular‐Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter , 1990 .
[13] M. Chatterjee,et al. Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. , 2004, Bioconjugate chemistry.
[14] E. Meijer,et al. Encapsulation of Guest Molecules into a Dendritic Box , 1994, Science.
[15] Thommey P. Thomas,et al. Targeting and inhibition of cell growth by an engineered dendritic nanodevice. , 2005, Journal of medicinal chemistry.
[16] P. Elwood,et al. Role of the membrane-associated folate binding protein (folate receptor) in methotrexate transport by human KB cells. , 1989, Archives of biochemistry and biophysics.
[17] K. Kono,et al. Water-soluble dendrimer-poly(ethylene glycol) starlike conjugates as potential drug carriers , 1999 .
[18] James R. Baker,et al. The Synthesis and Testing of Anti-Cancer Therapeutic Nanodevices , 2001 .
[19] E C Wiener,et al. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor. , 1997, Investigative radiology.
[20] J. Ross,et al. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications , 1994, Cancer.
[21] Francis C Szoka,et al. Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. , 2002, Bioconjugate chemistry.
[22] Sujatha Kannan,et al. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. , 2003, International journal of pharmaceutics.
[23] P. Elwood,et al. Studies of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells. , 1985, The Journal of biological chemistry.
[24] E. Meijer,et al. The dendritic box, shape-selective liberation of encapsulated guests , 1995 .
[25] N. Roehm,et al. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. , 1991, Journal of immunological methods.
[26] R Langer,et al. New methods of drug delivery. , 1990, Science.
[27] R. Barth,et al. Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy. , 1994, Bioconjugate chemistry.
[28] K. Kono,et al. Water-soluble dendritic unimolecular micelles: their potential as drug delivery agents. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[29] P. Low,et al. Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells. , 1993, Journal of cell science.
[30] J. Fréchet,et al. Designing dendrimers for drug delivery. , 1999, Pharmaceutical science & technology today.
[31] Anil K Patri,et al. Dendritic polymer macromolecular carriers for drug delivery. , 2002, Current opinion in chemical biology.
[32] J. Baker,et al. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[33] F. Szoka,et al. Polyester dendritic systems for drug delivery applications: design, synthesis, and characterization. , 2002, Bioconjugate chemistry.
[34] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[35] Jean M. J. Fréchet,et al. Dendrimers and other dendritic polymers , 2001 .
[36] F. Vögtle,et al. Dendrimers and Dendrons: Concepts, Syntheses, Applications , 2001 .
[37] William A. Goddard,et al. Starburst dendrimers. 5. Molecular shape control , 1989 .
[38] P. Low,et al. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[39] M. Brechbiel,et al. Biodistribution of a 153Gd-Folate Dendrimer, Generation = 4, in Mice With Folate-Receptor Positive and Negative Ovarian Tumor Xenografts , 2002, Investigative radiology.
[40] K. Kono,et al. Design of dendritic macromolecules containing folate or methotrexate residues. , 1999, Bioconjugate chemistry.